17. Syntheses and uses of isotopically labelled compounds |
929 |
6. Synthesis of the [4-13C]oct-1-en-3-one (81)
The 13C label has been introduced66 into 81 by the sequence in equation 34. The compound 81 was needed to explain the MS mechanism of the fragmentation of the 2-hydroxy-1,3-butadiene.
* |
|
LiA lH4 |
|
|
|
|
|
* |
|
PBr3 |
* |
|||||||
CH3 (CH2 )3 COOH |
|
|
|
|
|
|
CH3 |
(CH2 )3 CH2 OH |
|
|
CH3 (CH2 )3 CH2 Br |
|||||||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mg / ether |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
* |
|
|
|
|
|
|
|
|
|
|
|
|
acrolein / ether |
* |
||||
CH3 (CH2 )3 CH2 CH(OH)CH |
|
|
CH2 |
|
|
|
|
|
CH3 (CH2 )3 CH2 MgBr |
|||||||||
|
|
0 |
°C, 1 h, work-up |
|||||||||||||||
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
4 h |
|
MnO2 , under argon |
|
|
|
|
|
(34) |
|||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
O |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
CH3 (CH2 )3 CH2 CCH |
|
CH2 |
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
(81)89% yield
7.Synthesis of 13C- and 2H- labelled 2-phenylcyclododecanones
The commercially unavailable 2-phenylcyclododecanone-13C2 (82a and 82b) and perdeuterio-2-phenylcyclododecanone (83) have been synthesized67 69 to study the effects of magnetic isotopic substitution at the radical centres on the dynamics of flexible biradicals70,71. The compounds 82a and 82b have been synthesized in 8 steps as shown in equation 35. The 13C has been incorporated by treating 1,10-dibromodecane with two equivalents of K13CN (99% 13C).
O |
|
O |
O |
Ph |
Ph |
|
C6 D5 |
* * |
|
* |
* |
D2 1
(82a) |
(82b) |
(83) |
Perdeuterio-2-phenylcyclododecanone, 83, has been prepared67 by H/D exchange between unlabelled 2-phenylcyclododecanone and excess of D2O, catalysed by D2- reduced PtO2 in the presence of alkaline catalyst (D2O2 and NaOD) prepared by adding 30 mg of Na2O2 to 20 ml of D2O at 0 °C over 1 hour. The exchange reaction proceeded at 240 250 °C in autoclave for 78 hours under 1000 psi of nitrogen (equation 36). Photochemical studies using 13C-labelled 82 and perdeuteriated derivatives of 2-phenylcyclododecanones 83 are in progress.
930 |
|
|
Mieczysław Ziełinski´ and Marianna Kanska´ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
KCN, 95% EtOH |
|
|
KOH / H2 O |
||||||||||||
Br(CH2 )10 Br |
|
|
|
|
NC(CH2 )10 CN |
|
|
|
HOOC(CH2 )10 COOH |
|||||||||
|
|
|
|
|
30 h reflux |
|||||||||||||
|
|
|
80°C, 30 h reflux |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 h reflux |
|
MeOH / conc. HCl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MeOOC(CH2 )10 COOMe |
|||
|
|
|
|
110 − 120°C, 12 h under argon |
|
|
|
65% yield |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
Na / xylene, Me3 SiCl |
|
|
|
|
||||
OSiMe3 |
|
|
|
|
|
|
|
|
O |
|
|
|
O |
|
||||
|
|
|
OSiMe3 |
|
|
|
|
|
|
O |
|
OH |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
conc. HCl |
|
|
|
|
|
|
+ |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 min reflux |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
under argon |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 : |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60% yield |
|
|||
O |
|
|
|
|
3 h reflux |
|
|
|
|
|
|
|
O |
(35) |
||||
|
|
|
|
47% HI in H2 O / A c OH |
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Br |
Br |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
Br2 (2 equiv.)/ AcOH (81%) |
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 h RT |
|
|
|
|
|
|
|
|
|
|||
75% yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Et2 O, −78 °C |
|
|
RT (1 h) |
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Ph2 CuLi (2 equiv.) |
|
||||
|
|
|
|
|
|
O |
|
|
|
|
|
|
O |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ph |
Ph |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
+
(82a) |
(1 : 1) |
(82b) |
17. Syntheses and uses of isotopically labelled compounds |
931 |
|||||
O |
|
|
|
|
|
|
Ph |
|
|
|
|
|
|
|
PtO2 |
/ D2 , Na2 O2 |
/ D2 |
O |
|
|
|
|
|
|
|
83, 75% yield (95% deuterium isotopic purity) |
|
|
|
250 °C, 78 h |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
(36) |
8. Synthesis of [1,3-13C2]-4-(2,6,6-trimethylcyclohexen-1-yl)buten-2-one (ˇ-ionone)
(84)
84, a simplified retinoid, a useful tool to probe by NMR the conformation of proteinbound retinoids used to treat skin diseases and as cancer chemopreventive agents72,73, has been synthesized by aldol condensation of [1,3-13C2]acetone with ˇ-cyclocitral, 85, catalysed by aqueous sodium hydroxide74 (equation 37).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Me |
|
Me |
Me |
Me |
Me |
|
|
||
|
CHO |
|
|
|
O |
|
|
|
|
1, 3-13 C2 -acetone |
|
|
|
(37) |
|
|
|
|
|
|
|
|
|
|
10 % NaOH / H2O; 63 ° C, 9 days |
|
|
Me |
= 13 C |
|
|
|
Me |
|
|
|
|||
|
(85) |
|
|
|
(84) 73% yield, yellow oil |
|
9. Synthesis of 1,3,4-thiadiazol-2-ylcyanamide-[5-14C], sodium fLY217896-[5-
14C]Nag 86-[5-14C], and 1,3,4-thiadiazol-2-ylcyanamide-[UL-13C3] sodium fLY217 896-[UL-13C3] Nag, 86-[UL-13C]
The new anti-influenza agent, LY217896, 86, active against both A and B strains of influenza75, has been 14C and 13C labelled76 to support the pre-clinical as well as clinical drug 86 metabolism and disposition studies and to facilitate the identification of metabolism of 86 in vivo.
(a)LY217896-[5-14C], 86a, has been obtained in five steps which involve the formylation of thiosemicarbazide 87 with formic[14C] acid in the absent of solvent as the first reaction step (equation 38).
(b)The uniformly labelled LY217896[13C], 86b-[UL-13C], has been synthesized76 for
metabolite identification utilizing potassium cyanide, cyanogen bromide and formic acid more than 99.5 isotopically enriched with 13C (equation 39).
10. Synthesis of 2,3-disubstituted [3-13C]naphthalenes and [9a-13C]naphthol[2,3-d]- 1,2,3-oxadiazole
2-Amino-3-hydroxy[3-13C]naphthalene, 88, has been obtained77 in seven steps starting with 2-(1,3-dioxolan-2-yl)-benzyl chloride and Na13CN (equation 40). The diazotation of the labelled amino compounds 88 followed by deprotonation provided [9a-13C]naphthol [2,3-d]-1,2,3-oxadiazole, 89 (equation 41).
932 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
S
H2 N NHNH2
(87)
N
N
S
1. 85 °C, 0.5 h
+ H14 COOH |
|
|
|
|
|
N N |
|||
|
2. conc. H Cl, 85 ° C, 1h ; RT overnight |
||||||||
|
|
||||||||
|
|
|
3. 1N NaOH, work-up |
|
|
||||
|
|
|
|
|
|
|
|
|
NH2 |
|
|
|
overnight reflux |
|
|
|
|
S |
|
|
|
|
|
|
|
|
|
||
|
|
|
PhCH2 Cl / MeCN |
|
|
|
|
Bn |
|
|
|
|
|
|
|
|
|
|
|
Bn |
|
|
|
N |
N |
||||
|
|
|
|
|
|||||
|
|
BrCN / NaHCO3 |
|
|
|
|
|
||
|
MeOH / H2 O, 50−60 °C, 2 h, work-up |
|
|
NCN |
|||||
|
|
S |
|
|
|||||
NH.HCl |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
(38) |
||
|
|
|
|
|
|
||||
|
|
|
|
|
work-up |
|
|
A lCl3 / CH2 Cl2 |
|
|
|
|
|
|
|
|
|
|
|
N |
N |
|
N |
N |
|
NaOH / MeOH |
|
||||
|
|
|
|||
− + |
|
|
|||
EtOA c |
|
||||
|
|
||||
|
NCN Na |
S |
NHCN |
||
|
S |
|
|
(86a)-[5-14 C] |
|
|
LY217896-[5-14 C]Na, 24.8% yield |
|
= 14 C label |
r.purity ≥ 99.2% |
|
sp. act. 34.75 Ci / mg (5.14 mCi / mmol) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S |
|
|
|
|
|
K13 CN + S |
|
acetone |
NH2 NH2 , MeOCH2 CH2 OH |
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
KS13 CN |
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
4 h reflux |
|
130 °C, 2 h |
|
H2 N |
NHNH2 |
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H13 COOH |
|||
|
|
|
|
|
|
|
|
|
|
|
|
as in eq. 38 |
|
|
|
|
||
|
|
|
|
|
|
|
|
Bn |
|
|
|
|
|
N |
|
|||
|
|
|
|
|
|
N |
N |
|
|
|
|
|
|
|
N |
|||
|
|
|
|
|
|
|
|
BnCl / MeCN |
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
NH.HCl |
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
S |
|||||||
|
|
MeOH / H2 O |
S |
|
|
|
|
|
NH2 |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
Br13 CN / NaHCO3 |
|
|
|
|
|
|
|
|
|
|
||
|
|
Bn |
|
|
|
|
|
|
|
|
|
|
(39) |
|||||
N |
N |
|
|
|
|
|
|
N |
N |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
as in eq. 38 |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
N13 CN |
|
|
|
|
|
|
|
|
|||||||||
|
S |
NH13 CN |
|
|
|
|
|
|
|
|
||||||||
|
S |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
= 13 C, Bn = PhCH2 |
|
|
(86b) - [13 C] |
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
NaOH / MeOH |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
EtOA c |
|
N |
N |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
− |
13 |
|
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
S |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N |
CN Na |
(86) - as sodium salt
LY217896[UL-13 C]Na, 26.7% yield
17. Syntheses and uses of isotopically labelled compounds |
933 |
|||
O |
|
|
|
|
|
Na13 CN / MeCN |
|
1. NaOH / H2 O, reflux |
|
O |
|
2. H+(pH 4-5), (40 % H3 PO4 ) |
|
|
15-crown-5, 20 °C |
|
|
|
|
|
3. Et3 N |
|
||
|
|
CH2 CN |
|
|
CH2 Cl
O |
|
1. (EtO)2 P(O)CN, NCCH2 COOBu-t |
|
|
COOBu-t |
DMF, 20 °C, 3 h |
− + |
|
|
||
|
2. Work-up |
CH2 COO Et3 NH |
|
|
CN |
|
CN |
|
|
|
|
|
CF3 COOH / H2 O (trace) |
(40) |
|
|
20 °C, 3 h |
|
|
OH
COOMe
1.HCl / MeOH (anhydrous), 2 days under N2
2.H2 O (1 equivalent)
3. Work-up
OH
20 °C, 20 h NH3 / CH3 OH
CONH2
1. 3-(COOH)C6 H4 SO2 Cl, NaOH, H2 O 2. NaOCl / H2 O, 40 °C
OH
NH2
OH
(88)
+ −
N2 Cl
1. HCl, isopentyl nitrite
88 |
|
2. Work-up |
OH
1.Basic A l2 O3 (4 % H2 O) (exclusion of light)
(41)
2. Work-up
N
N
O
(89) 16.6% yield, m.p. + 77°C (decomp.), storage at −20°C
The ˇ-13C-labelled naphthalenes obtained have been characterized by their 13C-NMR chemical shifts and 13C 13C coupling constants determined in CD3OD.
934 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
11. Synthesis of [20,21-13C2]-pregnenolone (90)
90 labelled with 13C at C 20 and C 21 has been obtained78 by condensation of androst- 5-en-3ˇ-ol-17-one, 91, with K13CN and by Grignard reaction of nitrile derivative 92 with 13CH3MgI (equation 42). The location of carbon-13 was confirmed by 13C-NMR spectroscopy.
O
|
|
CN |
|
|
|
OH |
|
|
K13 CN (99 atom %) |
||
|
EtOH, A c OH |
|
|
HO |
|
t-butyldimethyl silyl chloride |
|
(91) |
|||
CN |
DMF, imidazole |
Phosphorus oxychloride
Py, RT, 72 h
TBDMSiO
Pd / C (10 %), H2 (1 atm.)
TBDMSiO
|
|
EtOA c, 7 h |
|
O |
|
(42) |
|
|
|
||
|
CN |
|
1.13 CH3 MgI, Et2 O, 40 h reflux under N2
2.0 °C, NH4 Cl/ H2 O, 2h
3.Work-up
|
|
|
+ − |
(92) |
|
|
|
|
1. (n-Bu)4 N F, THF, RT, 20 h |
|
|
|
2. Work-up |
|
|
||
|
|
|
|
||
|
|
|
|
|
O |
|
|
|
|
|
|
|
= Carbon − 13 |
|
|
|
|
|
|
|
HO |
|
|
|
|
|
|
|
|
|
|
|
|
(90) |
|
12. Synthesis of carbon-13 labelled 1-keto-7-methoxyoctahydrophenanthrene
The syntheses of carbon-13 labelled trans-tricyclic ketones 93 and 94 have been carried out79 via the cyanidation reaction of organoborane (equation 43). The isomerically pure trans-tricyclic ketones 93 and 94 were needed in connection with the undertaken synthesis
17. Syntheses and uses of isotopically labelled compounds |
935 |
of carbon-11-labelled 17ˇ-estradiol and related hormones80,81.
O
MeO
1.CH2 CHCH2 MgBr
2.H2 O
3.H3 PO4
+ conjugated isomer
MeO
Thexylborane / THF, 0°C
B
MeO
1.NaCN
2.TFA A
3.NaOH / H2 O2
4. Purifications
|
Me |
|
|
O 1. (i-Pr)2 NLi |
O |
2. Me l |
|
MeO |
MeO |
(93) |
(94) |
|
= Carbon −13 |
(43)
13. Synthesis of 1,2,3,4,-tetrahydrocarbazole-9a-13C and carbazole-9a-13C
The title 13C-labelled heterocyclic compounds have been synthesized82 to understand better the coal liquification process83, Cyclohexanone-1-13C, 95, has been prepared through the sequence of reactions shown in equation 44. The carbonation of 96 at 78 °C gave 95 in 24 38% yield. At 8°C, the condensation of 95 with excess of Grignard
936 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
reagent provided the alcohols 97, 98 and 99 and no 95 (equation 45). 100 and 101 have been prepared in 77% and 85% yields, respectively (equation 46), starting with 95. Several 13C-labelled compounds 100 have been synthesized also to study the effectiveness of hydrogen transfer solvents in coal liquification process84.
* |
|
|
|
|
|
H3 O |
+ |
|
|
|
|
||||
Br(CH2 )5Br KCN |
|
|
|
|
|||||||||||
|
|
|
|
|
|
NC(CH2 )5CN |
|
|
|
|
HOOC(CH2 )5COOH |
||||
|
|
|
|
|
|
|
|
|
|
||||||
|
Mg, Et2 O |
|
|
O |
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
1. 13 CO2 |
|
|
|
|
|
|
|
Ba(OH)2 |
(44) |
||
BrMg(CH2 )5MgBr |
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
2. H3 O+ |
|
|
|
|
|
|
|
|
|
|
|||||
(96) |
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
(95) |
|
|
|
|
|
|
|
O |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
HO |
C5H11 |
HO |
(CH2 )5COOH |
||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
1. BrMg (CH2 )5MgBr |
|
|
|
+ |
|
|
|
|
|||||
|
|
|
H3 O+ |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
(95) |
|
|
|
|
|
|
(97) |
|
|
|
|
|
(98) |
(45) |
|
|
|
|
|
|
|
|
|
|
|
|
HO |
|
(CH2 )5 |
OH |
+
(99)
1. A cOH, reflux
95 |
|
|
|
2. C6 H5NHNH2 , 1h reflux |
|||
|
|||
|
3. Work-up |
NH |
(100)
(46)
320 °C Pd / C
= Carbon-13
NH
(101)
17. Syntheses and uses of isotopically labelled compounds |
937 |
14. Synthesis of [10-13C]bilirubin IX˛ (102)
102, the major product of haem degradation, is poorly excreted in the newborn. Its accumulation leads to damage of the central nervous system. The tracer kinetic studies in vivo with the use of radiolabelled bilirubin have, because of ethical reasons, not involved neonates. [10-13C]bilirubin has therefore been synthesized85,86 in overall 6% yields to elucidate the pathophysiological mechanism of bilirubin metabolism in humans. The total synthesis of 102 presented by equation 47 involves the Vilsmeier formylation of one of the dipyrrolic fragments using [1-13C]dimethyl amide. The penultimate dehydrohalogenation reaction has been complicated by side elimination reaction leading to 2,18 bridged with propane ether biliverolin derivative87, 105. For these reasons the route shown in equations 47a, b, c seems not to be the most propitious approach and the use of phenylselenylethyl groups as protected vinyl substituents88 has been suggested.
Cl |
COOMe |
t-BuOOC
Cl
t-BuOOC
Cl
t-BuOOC
Me Me
+
NH |
AcOCH2 |
NH |
COOBn |
NiSMM
COOMe
Me Me
(47a)
NH |
NH |
COOBn |
THF / Et3 N 10 % Pd / C, H2 , RT
COOMe
Me Me
NH |
NH |
COOH |
(103)
NiSMM = Synthetic Mica Montmorillonite
with Incorporated Nickel
938 |
|
Mieczysław Ziełinski´ and Marianna Kanska´ |
|
|||
MeOOC |
|
Cl |
|
|
|
|
|
Me |
|
|
Me |
|
|
|
|
+ |
|
|
1. NiSMM / CH2 Cl2 |
|
|
|
|
|
2. Pd / C, Et3 N, THF / H2 |
|
|
BnOOC |
NH |
AcOCH2 |
NH |
COOBu-t |
|
|
|
|
|||||
|
|
|
|
MeOOC |
Cl |
|
1. CH2 Cl2 / MeOH / p-toluene sulphonic acid monohydrate |
Me |
Me |
||||
|
22 °C, 40 min (decarboxylation) |
|
|
2.CH2 Cl2 / POCl3 , [1-1 3 C]DMF, 20 ° C, 1.5h (formylation)
3.Work-up
|
|
|
HOOC |
NH |
NH |
COOBu-t |
MeOOC |
|
Cl |
|
|
|
|
|
|
Me |
Me |
|
|
|
|
|
|
|
103 TsOH, MeOH, CH2 Cl2 |
|
|
|
|
|
19 °C, 18 h stir., work-up, HBr |
|
||
|
* NH |
NH |
COOBu-t |
|
|
|
|
O |
(104) |
|
|
|
|
|
|
|
|
|
|
|
Cl |
|
|
Cl |
|
HO |
HO |
|
|
|
|
O |
O |
|
O |
O |
|
|
|
|
Cl |
|
|
Cl |
|
|
|
|
|
|
|
|
|
|
|
NH |
HN |
|
|
|
NH |
HN |
|
|
|
|
|||
|
|
|
|
|
||
|
|
TFA , Br2 |
, N2 |
− |
|
|
|
|
|
|
Br |
NH + |
|
N |
HN |
|
0−5 ˚C , 1.5 h |
|
HN |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MeOOC |
|
COOMe |
MeOOC |
|
COOMe |
|
|
|
|
|
|
(47b)
Py, 3 % NaOH
2 h reflux, work-up
O |
O |
(2) |
(18) |
|
|
NH |
HN |
N |
HN |
|
|
MeOOC |
COOMe |
(105)